MoneyWorks4Me

Sanjivani Paranteral - Quaterly Results

18 Oct 2023 Evaluate
A decent increase of about 68.08% in the turnover to Rs. 140.03 millions was observed for the quarter ended September 2023. The turnover stood at Rs. 83.31 millions during the similar quarter previous year.The Net Profit of the company reported a remarkable increase of 123.01% to Rs. 17.06  millions  from Rs. 7.65 millions in previous same quarter.Operating profit surged to 22.64 millions from the corresponding previous quarter of 12.99 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 140.03 83.31 68.08 265.84 182.48 45.68 354.92 306.13 15.94
Other Income 1.50 1.66 -9.64 2.10 2.83 -25.80 5.54 2.43 127.98
PBIDT 22.64 12.99 74.29 43.35 35.73 21.33 61.90 59.69 3.70
Interest 0.46 0.72 -36.11 0.89 1.46 -39.04 3.59 2.13 68.54
PBDT 22.18 12.27 80.77 42.46 34.27 23.90 58.31 57.56 1.30
Depreciation 2.32 2.17 6.91 4.61 4.34 6.22 8.88 8.77 1.25
PBT 19.86 10.10 96.63 37.85 29.93 26.46 49.43 48.79 1.31
TAX 2.80 2.45 14.29 5.30 4.31 22.97 4.33 0.32 1253.13
Deferred Tax 0.00 -0.05 0.00 0.00 -0.69 -100.00 -6.10 0.32 -2006.25
PAT 17.06 7.65 123.01 32.55 25.62 27.05 45.10 48.47 -6.95
Equity 99.98 99.98 0.00 99.98 99.98 0.00 99.98 99.98 0.00
PBIDTM(%) 16.17 15.59 3.69 16.31 19.58 -16.72 17.44 19.50 -10.55
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..